SEARCH

SEARCH BY CITATION

References

  • Aktan F. (2004) iNOS-mediated nitric oxide production and its regulation. Life Sci. 75, 639653, Review.
  • Andrews N. C. and Faller D. V. (1991) A rapid micro preparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res. 19, 2499.
  • Arce C., Del Campo A. B., Figueroa S., López E., Aránguez I., Oset-Gasque M. J. and González M. P. (2004) Expression and functional properties of group I metabotropic glutamate receptors in bovine chromaffin cells. J. Neurosci. Res. 75, 182193.
  • Baltrons M. A., Agulló L. and García A. (1995) Dexamethasone up-regulates a constitutive nitric oxide synthase in cerebellar astrocytes but not in granule cells in culture. J. Neurochem. 64, 447450.
  • Bolli R., Dawn B. and Xuan Y. T. (2003) Role of the JAK-STAT pathway in protection against myocardial ischemia/reperfusion injury. Trends Cardiovasc. Med. 13, 7279, Review.
  • Boyd C. S. and Cadenas E. (2002) Nitric oxide and cell signaling pathways in mitochondrial-dependent apoptosis. Biol. Chem. 383, 411423.
  • Bredt D. S. (1999) Endogenous nitric oxide synthesis: biological functions and pathophysiology. Free Radic. Res. 31, 577596, Review.
  • Bredt D. S., Ferris C. D. and Snyder S. H. (1992) Nitric oxide synthase regulatory sites. Phosphorylation by cyclic AMP-dependent protein kinase, protein kinase C, and calcium/calmodulin protein kinase; identification of flavin and calmodulin binding sites.. J. Biol. Chem. 267, 1097610981.
  • Calabrese V., Mancuso C., Calvani M., Rizzarelli E., Butterfield D. A. and Stella A. M. (2007) Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity. Nat. Rev. Neurosci. 8, 766775, Review.
  • Chung K. K. K. (2006) Say NO to neurodegeneration: role of S-nitrosylation in neurodegenerative disorders. Neurosignals 15, 307313.
  • Colasanti M., Persichini T., Menegazzi M., Mariotto S., Giordano E., Caldarera C. M., Sogos V., Lauro G. M. and Suzuki H. (1995) Rapid inactivation of NOS-I by lipopolysaccharide plus interferon-gamma-induced tyrosine phosphorylation. Biol. Chem. 270, 2673126733.
  • Conti A., Miscusi M., Cardali S., Germanò A., Suzuki H., Cuzzocrea S. and Tomasello F. (2007) Nitric oxide in the injured spinal cord: synthases cross-talk, oxidative stress and inflammation. Brain Res. Rev. 54, 205218, Review.
  • Dinerman J. L., Steiner J. P., Dawson T. M., Dawson V. and Snyder S. H. (1994) Cyclic nucleotide dependent phosphorylation of neuronal nitric oxide synthase inhibits catalytic activity. Neuropharmacology 33, 12451251.
  • Fedorov R., Hartmann E., Ghosh D. K. and Schlichting I. (2003) Structural basis for the specificity of the nitric-oxide synthase inhibitors W1400 and Nω-propyl-L-Arg for the inducible and neuronal isoforms. J. Biol. Chem. 278, 4581845825.
  • Figueroa S., López E., Arce C., Oset-Gasque M. J. and González M. P. (2005) SNAP, a NO donor, induces cellular protection only when cortical neurons are submitted to some aggression process. Brain Res. 1034, 2533.
  • Förstermann U., Boissel J. P. and Kleinert H. (1998) Expressional control of the ‘constitutive’ isoforms of nitric oxide synthase (NOS I and NOS III). FASEB J. 12, 773790, Review.
  • Garvey E. P., Oplinger J. A., Furfine E. S., Kiff R. J., Laszlo F., Whittle B. J. and Knowles R. G. (1997) 1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo. J. Biol. Chem. 272, 49594963.
  • Golde S., Coles A., Lindquist J. A. and Compston A. (2003) Decreased iNOS synthesis mediates dexamethasone-induced protection of neurons from inflammatory injury in vitro. Eur. J. Neurosci. 8, 25272537.
  • González M. P., Herrero M. T., Vicente S. and Oset-Gasque M. J. (1998) Effect of glutamate receptor agonists on catecholamine secretion in bovine chromaffin cells. Neuroendocrinology 67, 181189.
  • Hayashi Y., Nishio M., Naito Y., Yokokura H., Nimura Y., Hidaka H. and Watanabe Y. (1999) Regulation of neuronal nitric-oxide synthase by calmodulin kinases. J. Biol. Chem. 274, 2059720602.
  • Kim P. K., Zamora R., Petrosko P. and Billiar T. R. (2001) The regulatory role of nitric oxide in apoptosis. Int. Immunopharmacol. 1, 14211441.
  • Kleinert H., Pautz A., Linker K. and Schwarz P. M. (2004) Regulation of the expression of inducible nitric oxide synthase. Eur. J. Pharmacol. 500, 255266.
  • Knowles R. G., Salter M., Brooks S. L. and Moncada S. (1990) Anti-inflammatory glucocorticoids inhibit the induction by endotoxin of nitric oxide synthase in the lung, liver and aorta of the rat. Biochem. Biophys. Res. Commun. 172, 10421048.
  • Korhonen R., Lahti A., Hämäläinen M., Kankaanranta H. and Moilanen E. (2002) Dexamethasone inhibits inducible nitric-oxide synthase expression and nitric oxide production by destabilizing mRNA in lipopolysaccharide-treated macrophages. Mol. Pharmacol. 62, 698704.
  • Lin Y., Yao S., Veach R., Torgerson T. and Hawiger J. (1995) Inhibition of nuclear translocation of transcription factor NFkappa B by a synthetic peptide containing a cell membrane permeable motif and nuclear localization sequence. J. Biol. Chem. 270, 1425514258.
  • Linn S. C., Morelli P. J., Edry I., Cottongim S. E., Szabo C. and Salzman A. L. (1997) Transcriptional regulation of human inducible nitric oxide synthase gene in an intestinal epithelial cell line. Am. J. Physiol. 35, G1499G1508.
  • Liu B., Gao H. M., Wang J. Y., Jeohn G. H., Cooper C. L. and Hong J. S. (2002) Role of nitric oxide in inflammation-mediated neurodegeneration. Ann. NY Acad. Sci. 962, 318331.
  • Madhusoodanan K. S. and Murad F. (2007) NO-cGMP signaling and regenerative medicine involving stem cells. Neurochem. Res. 32, 681694.
  • Mariotto S., Menegazzi M. and Suzuki H. (2004) Biochemical aspects of nitric oxide. Curr. Pharm. Des. 10, 16271645, Review.
  • Minc-Golomb D., Yadid G., Tsarfaty I., Resau J. H. and Schwartz J. P. (1996) In vivo expression of inducible nitric oxide synthase in cerebellar neurons. J. Neurochem. 66, 15041509.
  • Misko T. P., Schilling R. J., Salvemini D., Moore W. M. and Currie M. G. (1993) A fluorimetric assay for the measurement of nitrite in biological samples. Anal. Biochem. 214, 1116.
  • Nakamura T., Gu Z. and Lipton S. A. (2007) Contribution of glutamatergic signaling to nitrosative stress-induced protein misfolding in normal brain aging and neurodegenerative diseases. Aging Cell. 6, 351359.
  • Nakane M., Mitchell J., Förstermann U. and Murad F. (1991) Phosphorylation by calcium calmodulin-dependent protein kinase II and protein kinase C modulates the activity of nitric oxide synthase. Biochem. Biophys. Res. Commun. 180, 13961402.
  • Nomura Y. (2004) Neuronal apoptosis and protection: effects of nitric oxide and endoplasmic reticulum-related proteins. Biol. Pharm. Bull. 27, 961963.
  • Oset-Gasque M. J., Parramón M., Hortelano S., Boscá L. and González M. P. (1994) Nitric oxide implication in the control of neurosecretion by chromaffin cells. J. Neurochem. 63, 16931700.
  • Pérez-Rodríguez R., Fuentes M. P., Olivan A. M., Martínez-Palacian A., Roncero C., González M. P. and Oset-Gasque M. J. (2007) Mechanisms of nitric oxide-induced apoptosis in bovine chromaffin cells: role of mitochondria and apoptotic proteins. J. Neurosci. Res. 85, 22242238.
  • Reynaert NL, Ckless K, Korn SH, Vos N, Guala AS, Wouters EF, Van Der Vliet A and Janssen-Heininger YM. (2004) Nitric oxide represses inhibitory kappaB kinase through S-nitrosylation. Proc. Natl Acad. Sci. USA 101, 89458950.
  • Sastry P. S. and Subba K. R. (2000) Apoptosis and the nervous system. J. Neurochem. 74, 120.
  • Schwarz P. M., Gierten B., Boissel J. P. and Förstermann U. (1998) Expressional down-regulation of neuronal-type nitric oxide synthase I by glucocorticoids in N1E-115 neuroblastoma cells. Mol. Pharmacol. 54, 258263.
  • Shinoda J., McLaughlin K. E., Bell H. S., Swaroop G. R., Yamaguchi S., Holmes M. C. and Whittle I. R. (2003) Molecular mechanisms underlying dexamethasone inhibition of iNOS expression and activity in C6 glioma cells. Glia 42, 6876.
  • Spitsin S. V., Koprowski H. and Michaels F. H. (1996) Characterization and functional analysis of the human inducible nitric oxide synthase gene promoter. Mol. Med. 2, 226235.
  • Stempelj M., Kedinger M., Augenlicht L. and Klampfer L. (2007) Essential role of the JAK/STAT1 signalling pathway in the expression of inducible nitric-oxide synthase in intestinal epithelial cells and its regulation by butyrate. J. Biol. Chem. 282, 97979804.
  • Togashi H., Sasaki M., Frohman E., Taira E., Ratan R. R., Dawson T. M. and Dawson V. L. (1997) Neuronal (type I) nitric oxide synthase regulates nuclear factor kappaB activity and immunologic (type II) nitric oxide synthase expression. Proc. Natl Acad. Sci. USA 94, 26762680.
  • Turquier V., Vaudry H., Yon L., Hsu C. M., Ait-Ali D., Grumolato L., Eiden L. E. and Anouar Y. (2002) Proinflammatory cytokines TNF-alpha and IL-1alpha stimulate neuropeptide gene expression in adrenochromaffin cells. Ann. NY Acad. Sci. 971, 4548.
  • Vicente S., González M. P. and Oset-Gasque M. J. (2002) Neuronal nitric oxide synthase modulates basal catecholamine secretion in bovine chromaffin cells. J. Neurosci. Res. 69, 327340.
  • Vicente S., Pérez-Rodríguez R., Oliván A. M., Martínez-Palacián A., González M. P. and Oset-Gasque M. J. (2006) Nitric oxide and peroxynitrite induce cellular death in bovine chromaffin cells: evidence for a mixed necrotic and apoptotic mechanism with caspases activation. J. Neurosci. Res. 84, 7896.
  • Wang H., Wu Y. B. and Du X. H. (2005) Effect of dexamethasone on nitric oxide synthase and caspase-3 gene expressions in endotoxemia in neonate rat brain. Biomed. Environ. Sci. 18, 181186.
  • Yu Z., Zhang W. and Kone B. C. (2002) Signal transducers and activators of transcription 3 (STAT3) inhibits transcription of the inducible nitric oxide synthase gene by interacting with nuclear factor kappaB. Biochem. J. 367, 97105.
  • Zhang H. Q., Fast W., Marletta M. A., Martasek P. and Silverman R. B. (1997) Potent and selective inhibition of neuronal nitric oxide synthase by N omega-propyl-L-arginine. J. Med. Chem. 40, 38693870.
  • Zhong H. and Minneman K. P. (1993) Close reciprocal regulation of beta 1- and beta 2-adrenergic receptors by dexamethasone in C6 glioma cells: effects on catecholamine responsiveness. Mol. Pharmacol. 44, 10851093.
  • Ziesché E., Bachmann M., Kleinert H., Pfeilschifter J. and Mühl H. (2007) The interleukin-22/STAT3 pathway potentiates expression of inducible nitric-oxide synthase in human colon carcinoma cells. J. Biol. Chem. 282, 1600616015.